• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of mechanism on enhancement of fibrinolysis as biological defense

Research Project

Project/Area Number 13470519
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Laboratory medicine
Research InstitutionMie University

Principal Investigator

WADA Hideo  Mie University, Faculty of Medicine, Associate Professor, 医学部, 助教授 (40158704)

Co-Investigator(Kenkyū-buntansha) NAKATANI Kaname  Mie University, Faculty of Medicine, Assistant, 医学部, 助手 (80237304)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥10,100,000 (Direct Cost: ¥10,100,000)
Fiscal Year 2002: ¥4,900,000 (Direct Cost: ¥4,900,000)
Fiscal Year 2001: ¥5,200,000 (Direct Cost: ¥5,200,000)
Keywordsold age / fibrinolysis / tPA / PAI-I / TAFI / PAI-I polymorphism / DIC / t-PA-PAI-I complex / PAI-Iプロモーター領域ポリモルフィズム
Research Abstract

The prevention of the thrombosis in the old people becomes an important problem. The aging seemed to be large risk of the thrombosis, and we examined the relation between hemostasis abnormality and aging. In the examination of the maintenance dialysis patient, the death and crisis frequency which accompanied thrombosis increased with the aging. With the aging, there were calcification of the aorta and progress of the arteriosclerosis. In more than 70 years old of healthy volunteer, antithrombin and protein C reduced and thrombin- antithrombin complex and soluble fibrin levels were increased. While, in those, fibrinogen and fibrin degradation products and plasmin- plasmin inhibitor complex levels were increased, suggesting that hyperfibrinolysis exist in old peoples. However old health peoples had no secondary fibrinolysis due to thrombosis. These results indicated that physiological enhancement in fibrinolytic system was caused by aging. There are plasminogen activator (t-PA), plasmino … More gen activator inhibitor (PAI)-I, II, III and thrombin activatable fibrinolysis inhibitor (TAFI) in regulatory system of fibrinolysis. We established the usefulness of measurement in total PAI-I, tPA-PAI-I complex, TAFI and tPA by ELISA for the diagnosis of disseminated intravascular coagulation (DIG), deep vein thrombosis (DVT), and multiple organ failure (MOF) and acute myocardial infarction. As plasma levels of total PAI-I and TAFI were increased in old peoples, these factors may play an important role of the onset in thrombosis. It was suggested that elevated plasma levels of PAI-I was related to the polymorphism of promoter in PAI-I gene (4G/5G). After informed consent, the polymorphism of promoter in PAI-I gene (4G/5G) was examined in old peoples.
There was no significant difference of distribution in the polymorphism between young peoples and old peoples. Our results showed no relationship between polymorphism of PAI-I gene promoter and thrombosis in old peoples. Finally, old peoples had high risk for thrombosis and significant atherosclerosis, however they were in hyperfibrinolytic state. Less

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (34 results)

All Other

All Publications (34 results)

  • [Publications] Nakasaki T, Wada H, et al.: "Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer"Am J Hematol. 69・3. 247-254 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Mori Y, Wada H, et al.: "Defective von Willebrand factor-cleaving activity on admission is a marker of excellent clinical response to plasma exchange in patients with thrombotic thrombocytopenic purpura"Transfusion. 42・5. 572-580 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tamaki S, Wada H, et al.: "Hemostatic abnormalities following bone marrow transplantation"Clin Appl Thromb Hemost. 8・1. 125-132 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Wada H, Mori Y, et al.: "High plasma levels of fibrinogen are associated with poor outcome"Am J Hematol. 72・1. 1-7 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kusiya F, Wada H, et al.: "Atherosclerotic and hemostatic abnormalityes in patients undergoing Hemodialysis"Clin Appl Thromb Hemost. 9・1. 53-60 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Sase T, Wada H, et al.: "Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases"Thromb Haemost. 89・4. (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Mori Y, Wada H, et al: "Increased plasma thrombomodilin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome"Clin Appl Thromb Haemost. 7. 5-9 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Watanabe Y, Ito M, Kataoka Y, Wada H, et al: "Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin pbosphatase is involved in human platelet secretion"Blood. 97. 3798-3805 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Watanabe R, Wada H, et al: "Plasma levels of total plasminogen activator inhibitor -I and tissue plasminogen activator/inhibitor complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura"Clin Appl Thromb Haemost. 7. 229-233 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Watanabe R, Wada H, et al: "Plasma levels of thrombin activatable fibrinolysis inhibitor in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura"Thromb Res. 104. 1-6 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Taylor Jr FB, Haddad PA, Hack E, Chang AC, Peer GT, Morrissey JH, Li A, Allen RC, Wada H, et al: "Two stage response to endotoxin infusion into normal human subjects : Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response"Crit Care Med. 29. 326-334 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Taylor Jr FB, Toh CH, Hoots K, Wada H, et al: "Towards a definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation"Thromb Haemost. 86. 1327-1330 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kitai T, Nishikawa M, Tanigawa T, Okinaka T, Wada H, et al: "Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary,artery disease"Am Heart J. 142. (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Wada H, et al: "Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E.coli sepsis - Toward a distinct between uncompensated overt DIC and compensated non-overt DIC"Thromb Haemost. 86. 1489-1494 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nakasaki T, Wada H, et al: "Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer"Am J Hematol. 69. 247-254 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Mori Y, Wada H, et al: "Defective von Willebrand factor-cleaving activity on admission is a marker of excellent clinical response to plasma exchange in patients with thrombotic thrombocytopenic purpura"Transfusion. 42. 572-580 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Tamaki S, Wada H, et al: "Hemostatic abnormalities following bone marrow transplantation"Clin Appl Thromb Hemost. 8. 125-132 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Wada H, et al: "Plasma levels of plasminogen activator inhibitor-I(PAI-I) and thrombin activatable fibrinolysis inhibitor(TAFI) in patients with disseminated intravascular coagulation"Turkey J Hematol. 19. 235-237 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Noda A, Wada H, et al: "Plasma levels of heparin cofactor II(HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation"Clin Appl Thrombosis/Hemostasis. 8. 265-271 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] 0hta S, Wada H, et al: "Evaluation of tissue factor antigen level in human seminal plasma"Urol Res. 30. 317-320 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ohta S, Wada H, et al: "Fuse H : Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer"Anticancer Res.. 22. 2991-2996 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Wada H, et al: "High plasma levels of fibrinogen are associated with poor outcome"Am J Hematol. 72. 1-7 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Nakasaki T, Wada H, et al.: "Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer"Am J Hematol. 69・3. 247-254 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Mori Y, Wada H, et al.: "Defective von Willcbrand factor-cleaving activity on admission is a marker of excellent clinical response to plasma exchange in patients with thrombotic thrombocytopenic purpura"Transfusion. 42・5. 572-580 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Tamaki S, Wada H, et al.: "Hemostatic abnormalities following bone marrow transplantation"Clin Appl Thromb Hemost. 8・1. 125-132 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Wada H, Mori Y, et al.: "High plasma levels of fibrinogen are associated with poor outcome"Am J Hematol. 72・1. 1-7 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kusiya F, Wada H, et al.: "Atherosclerotic and hemostatic abnormalityes in patients undergoing Hemodialysis"Clin Appl Thromb Haemost. 9・1. 53-60 (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Sase T, Wada H, et al.: "Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases"Thromb Haemost. 89・4(印刷中). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Mori Y, Wada H, et al.: "Increased plasma thrombomodilin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and homolytic uremic syndrome"Clin Appl Thromb Haemost. 7. 5-9 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Watanabe Y, Wada H, et al.: "Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion"Blood. 97. 3798-3805 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Watanabe R, Wada H, et al.: "Plasma levels of total plasminogen activator inhibitor-1 and tissue plasminogen activator/inhibitor complex In patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura"Clin Appl Thromb Haemost. 7. 229-233 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Watanabe R, Wada H, et al.: "Plasma levels of thrombin activatable fibrinolysis inhibitor in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura"Thromb Res. 104. 1-6 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Wada H, Yamamuro M, et al.: "Comparison of the responses of global tests of coagulation with molecular markers of neutrophil,endothelial,and hemostatic system perturbation in the baboon model of E.coli sepsis-Toward a distinct between uncompensated over DIC and compensated non-overt DIC"Thromb Haemost. 86. 1489-1494 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Nakasaki T, Wada H, et al.: "Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer"Am J Hematol. (in press)(印刷中). (2002)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi